LYTIR

Company · AHCO

AdaptHealth Corp.

Nasdaq's symbol directory lists AHCO on Nasdaq as “AdaptHealth Corp. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($393K); insiders sold on 1 occasion ($118K); 2 planned-sale notices; 3 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $393K in total; Insider sales: $118K in total.Jul: Insider sales $118KAug: Insider purchases $393KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $393KInsider sales below: $118K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Dale B. Wolf bought on 2 days latest Aug 7, 2026 bought $243K
  2. Kenneth A. Samet bought on 1 day latest Aug 6, 2026 bought $150K
  3. Schuster III Russell E., Chief Commercial Officer sold on 1 day all under a 10b5-1 plan latest Jul 1, 2026 sold $118K
Every trade (4)
  1. BUYDale B. Wolf bought Aug 7, 2026 20,000 shares filing $117K
  2. BUYKenneth A. Samet bought Aug 6, 2026 23,500 shares filing $150K
  3. BUYDale B. Wolf bought Aug 6, 2026 20,000 shares filing $126K
  4. SELLSchuster III Russell E., Chief Commercial Officer sold Jul 1, 2026 11,275 shares 10b5-1 plan (scheduled) filing $118K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. JASON A CLEMENS filed Nov 6, 2026 Former CFO 60,978 shares planned sale date 11/06/2026 filing $448K
  2. JASON A CLEMENS filed Nov 5, 2026 Former CFO 169,779 shares planned sale date 11/05/2026 filing $1.3M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 10,814,727 shares filing 7.9%
  2. REINHART PARTNERS, LLC. filed Oct 13, 2026 Schedule 13G/A passive 0 shares filing 0%
  3. Dimensional Fund Advisors LP filed Oct 8, 2026 Schedule 13G/A passive filing 4.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 3, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.